GTGianni Testino

Gianni Testino

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gianni Testino has a total of 104 co-authors. Here are the top co-authors by number of shared publications:

  • Patrizia Balbinot

    Unit of Addiction and Hepatology/Alcohological Regional Centre, ASL3-ATS Liguria, IRCCS AOM, San Martino Polyclinic Hospital, Genoa, Italy

    49 shared publications
  • Rinaldo Pellicano

    Unit of Gastroenterology, Molinette Hospital, Torino, Italy

    46 shared publications
  • Silvia Leone

    Unit of Addiction and Hepatology, Alcohological Regional Center, ASL3, San Martino Polyclinic Hospital, Genoa, Italy

    25 shared publications
  • Rinaldo Pellicano

    Department of Gastroenterology, Molinette-SGAS Hospital, Turin, Italy

    20 shared publications
  • Fabio Caputo

    Center for the Study and Treatment of Alcohol-Related Diseases, Department of Translational Medicine, University of Ferrara, Ferrara, Italy

    18 shared publications
  • A. Sumberaz

    Department of Gastroenterology and Digestive Endoscopy, S. Martino Hospital Genoa

    15 shared publications

Latest Publications

  • Lower extremity arterial disease and alcohol consumption

    by Gianni Testino, Patrizia Balbinot

    Article: Lower extremity arterial disease and alcohol consumption - International Angiology 2026 Feb 02 - Minerva Medica - Journals

  • Management of metabolic dysfunction-associated steatotic liver disease

    by Gianni Testino

    Article: Management of metabolic dysfunction-associated steatotic liver disease - Minerva Endocrinology 2025 Dec 12 - Minerva Medica - Journals

  • The future of alcoholic liver disease management

    by Gianni Testino, Patrizia Balbinot, Fabio Caputo

    Alcohol-related liver disease (ALD) is one of the most prevalent causes of liver disease. It is the leading cause of cirrhosis, accounting for almost 60%. Moreover, it is the leading cause of liver transplant. Hepatologists are underpreparated to diagnose and treat alcohol use disorder (AUD) despite its high prevalence. The aim of this narrative review is to suggest a cultural and organizational change of a hepatology unit. This narrative review is based on a detailed analysis of the scientific literature published before January 31st, 2025 and examining the most recent papers on alcohol-related liver disease and hepatology unit organization (PubMed, Web of Science, Scopus, Google Scholar). Hepatology Unit must acquire alcohol and social skills autonomously. In association with liver injury treatment, it is necessary to set up addiction therapy in relation to liver damage severity and manage social vulnerability. The latter significantly influences the therapeutic path (mainly in case of inclusion on the list for a liver transplant). Therefore, in addition to cultural change (AUD skills), it is mandatory that the new organization provides the introduction of an authentic multi-professional activity, the formal caregiver and the self-help groups facilitator. The ability to identify hazardous/harmful alcohol consumption or alcohol use disorder is necessary. This is essential to clinically define steatotic liver disease. If this does not happen, the clinical outcome is compromised. Identification of a low-risk alcohol consumption in case of metabolic associated steatotic liver disease is necessary. In fact, it is known that ethanol in case of metabolic syndrome induces fibrogenesis at low dosage. Competence to manage harmful alcohol consumption and AUD is necessary (pharmacotherapy: intoxication, craving, withdrawal syndrome and psychotherapy). It is necessary to manage family and social problems that may prohibit inclusion in the liver transplantation list. Training and support of informal caregivers is necessary (introduction of the formal caregiver). Collaboration with self-help groups associations is necessary (introduction of the self-help groups facilitator). Collaboration with associations or charities for the management of fragile patients affected by AUD (homeless, migrants, prisoners, etc.).


  • Open Access

    Alcohol-related hepatocellular carcinoma: surveillance and primary prevention

    by Gianni Testino

    Alcohol-related hepatocellular carcinoma: Surveillance and primary prevention


  • Pollution and health: the role of healthy lifestyle

    by Gianni Testino, Patrizia Balbinot

    Article: Pollution and health: the role of healthy lifestyle - Minerva Medica 2025 Nov 20 - Minerva Medica - Journals

  • Fetal alcohol spectrum disorders prevention: is it necessary?

    by Patrizia Balbinot, Gianni Testino

    Article: Fetal alcohol spectrum disorders prevention: is it necessary? - Minerva Pediatrics 2025 Mar 25 - Minerva Medica - Journals

  • Alcohol use disorder: who thinks about addiction? The role of mutual-self-help

    by Patrizia Balbinot, Gianni Testino

    In this narrative review, some main points have been addressed. This is to better understand the daily clinical reality. The points are the following: alcohol use disorder (AUD) is not a "self-inflicted disease" but a clinical problem that derives from an incorrect lifestyle; possible presence of psychiatric pathology; possible presence of previous traumas; link with the substance (addiction). This review is based on a detailed analysis of the scientific literature published before January 31, 2025 and examining the most recent guidelines or position papers on alcohol use disorder treatment (PubMed, Web of Science, Scopus, Google Scholar). The alcohol problem is identified with addiction, ignoring that the close "bond" with the substance is acquired through a continuum that slips into slavery. The starting points of consumption are innumerable: pure pleasure, self-medication (psycho pathology, traumas, etc.), improvement of the relationship, etc. Also, for neuro-physio-pathological reasons, the concept of "self-inflicted disease" ceases to exist, especially when the onset of substance use is promoted and favored by society itself. During AUD, previous traumas, individual or social stresses favor, support and create the conditions to "defend" alcohol consumption. However, the self-referential release of alcohol represents the rule and if the primum movens is removed, the addictive experience is unlikely to end. Furthermore, the pharmacodynamic profile of alcohol is able to cause the phenomenology of the main psychotic symptoms in a way that is completely superimposable to that presented by subjects without a history of alcohol use disorder. We do not know whether the chicken or the egg came first. The distinction between use and induced disorders is fundamental but, in fact, not always practicable because, often, the induction of symptoms by the substance cannot be excluded, given that there is not a sufficient period of abstinence. Therefore, it is possible to confuse an induced disorder with a phenomenon of comorbidity, and therefore overestimate the dual diagnosis. It is important to understand whether or not a psychiatric problem is present, define the diagnosis and use the right pharmacological therapy at the lowest possible dosage. Neglecting it means undermining the therapeutic-rehabilitative path. In light of the scientific evidence presented in the present narrative review, it is possible to draw some conclusions. Firstly, AUD should not be considered as a "self-inflicted disease" but a clinical problem that derives from an incorrect lifestyle. Secondly, the possible presence of psychiatric pathology (primary or secondary) must be evaluated after a prolonged period of abstinence. Thirdly, psychotherapeutic activity is effective for the resolution of problems from post-traumatic stress and in helping the patient in motivation and change. Moreover, the treatment of psycho-pathological problems and those related to traumatic/stressful factors facilitates the maintenance of sobriety, but does not represent the key to interpretation. As already stated, "the self-referential release of alcohol and other psychotropic substances represents the rule and it is difficult to conclude the additive experience if the primum movens is removed." The key treatment to significantly address the "pathological bond with the substance" is the frequency and full adherence to self-help groups. The effectiveness is independent of routine pharmacological/psychotherapeutic treatments. Lastly, the number of subjects and family members who currently attend is negligible. For this reason, it is appropriate that services provide themselves with self-help facilitators and train informal caregivers.